Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic importance of sodium level trajectory in acute heart failure.
Matsue Y, Yoshioka K, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: satoh y. Heart Vessels. 2017 Dec;32(12):1498-1505. doi: 10.1007/s00380-017-1020-5. Epub 2017 Jul 11. Heart Vessels. 2017. PMID: 28698994 Clinical Trial.
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Matsue Y, Suzuki M, Nagahori W, Yoshida K, Onishi Y, Satoh Y, Ono Y, Nishioka T, Noda M, Sugi K, Torii S, Tejima T, Sakurada H, Yamaguchi S, Okishige K, Fujii H, Takahashi A. Matsue Y, et al. Among authors: satoh y. Cardiovasc Drugs Ther. 2014 Feb;28(1):73-7. doi: 10.1007/s10557-013-6491-8. Cardiovasc Drugs Ther. 2014. PMID: 24048511 Clinical Trial.
Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: satoh y. Int J Cardiol. 2016 Oct 15;221:188-93. doi: 10.1016/j.ijcard.2016.07.063. Epub 2016 Jul 5. Int J Cardiol. 2016. PMID: 27404673 Clinical Trial.
Corrigendum to "Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction" Journal of Cardiac Failure, Vol. 22, No. 6, June 2016, pp. 423-432.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: satoh y. J Card Fail. 2016 Nov;22(11):941. doi: 10.1016/j.cardfail.2016.07.434. Epub 2016 Jul 29. J Card Fail. 2016. PMID: 27481596 No abstract available.
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, van der Meer P, Damman K, Voors AA, Goldsmith SR. Matsue Y, et al. Among authors: satoh y. Clin Res Cardiol. 2017 Oct;106(10):802-812. doi: 10.1007/s00392-017-1122-1. Epub 2017 May 24. Clin Res Cardiol. 2017. PMID: 28540483 Free PMC article. Clinical Trial.
Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.
Nomoto H, Satoh Y, Kamiyama M, Yabe K, Masumura M, Sakakibara A, Yamashita S, Suzuki M, Sugiyama T, Oumi T, Ohno M, Takahashi Y, Isobe M. Nomoto H, et al. Among authors: satoh y. Int Heart J. 2017 Aug 3;58(4):593-600. doi: 10.1536/ihj.16-438. Epub 2017 Jul 13. Int Heart J. 2017. PMID: 28701677 Free article. Clinical Trial.
Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial.
Asakura M, Ito S, Yamada T, Saito Y, Kimura K, Yamashina A, Hirayama A, Kobayashi Y, Hanatani A, Tsujimoto M, Yasuda S, Abe Y, Higashino Y, Tamaki Y, Sugino H, Niinuma H, Okuhara Y, Koitabashi T, Momomura SI, Asai K, Nomura A, Kawai H, Satoh Y, Yoshikawa T, Hirata KI, Yokoi Y, Tanaka J, Shibata Y, Maejima Y, Tamaki S, Kawata H, Iwahashi N, Kobayashi M, Higuchi Y, Kada A, Yamamoto H, Kitakaze M. Asakura M, et al. Among authors: satoh y. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):108-117. doi: 10.1093/ehjcvp/pvaa132. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33175088 Clinical Trial.
Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER).
Asakura M, Yamamoto H, Asai K, Hanatani A, Hirata K, Hirayakma A, Kimura K, Kobayashi Y, Momomura S, Nakagawa Y, Nishi Y, Saito Y, Satoh Y, Yamada T, Yamashina A, Yasuda S, Yoshikawa T, Kada A, Uesaka H, Kitakaze M; EARLIER investigators and study coordinators. Asakura M, et al. Among authors: satoh y. Cardiovasc Drugs Ther. 2015 Apr;29(2):179-85. doi: 10.1007/s10557-014-6565-2. Cardiovasc Drugs Ther. 2015. PMID: 25566817 Clinical Trial.
1,555 results